Behavioral Neuroscience – Products

Company expands its targeted sequencing portfolio.

Rapid detection of designer drugs known as “Bath Salts,” including Mephedrone, Methcathinone, MDPV and their metabolites.

Service for individuals with developmental delay and autism spectrum disorders.

Provides real-time capture of neural activities.

New research published in BioMed Central’s open access journal Child and Adolescent Psychiatry and Mental Health shows that a teaching program, designed to improve the child’s knowledge about their sibling’s disease and to give them coping skills, was able to improve their adjustment and psychological well being in this early time period after diagnosis.

The most advanced scientific graphing and statistical analysis software now with an enriched user interface, increased ease of use and a host of additional new features.

Used to analyze and report information about variations and changes in genes and proteins to improve disease treatment, the GQ-DxSM product will launch immediately for the scientific and clinical communities seeking practical and efficient ways to translate advances from whole-genome sequencing into clinical application. GQ-Dx, based on the company’s GQ-Engine, provides comprehensive genomic information capabilities at clinical scale, including:

New portfolio to offer Definiens Tissue Studio®, Definiens Developer XD™ and Definiens Image Miner™.

Publication of study data to identify complex changes in blood gene expression patterns.